news

Scientists uncover how sunlight on skin reduces eczema inflammation

A new study has identified how exposure to sunlight alleviates symptoms of eczema by triggering the release of a compound in the skin that dampens inflammation.

eczema

The MRC researchers say their findings pave the way for new therapies that mimic the effects of the sun’s rays without its damaging side effects.

People with severe eczema are often prescribed UV light therapy, using tanning lamps, which can improve the itchy skin lesions associated with the condition. 

However, the UV can have damaging side effects on their skin, including burning, ageing and raising their skin cancer risk.

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

New study

The study, published in the Journal of Allergy and Clinical Immunology, found that exposing a small patch of skin on healthy volunteers to UV light triggered nitric oxide to be released into the blood stream.

Further lab studies found that the chemical activated specialised immune cells, called regulatory T cells, which act to dampen the ongoing inflammatory immune response.

In patients with eczema, the proportion of these regulatory T cells in their blood following light therapy directly correlated with disease improvement.

Therapeutic leads

Researchers say their findings could lead to new therapies for eczema, which affects around one in five children and one in 20 adults in the UK.

Lead researcher Dr Anne Astier, from the MRC Centre for Inflammation Research at the University of Edinburgh, said: 

“Our findings suggest that nitric oxide has powerful anti-inflammatory properties and could offer an alternative drug target for people with eczema. Activating regulatory T cells using this pathway may also provide a target for developing treatments for other conditions with overactive immune responses, including autoimmune diseases and rejection of transplants.”

Professor Richard Weller, a co-senior author on the study from the University of Edinburgh Medical School, said:

“It is clear that the health benefits of sunlight stretch far beyond vitamin D and we are starting to fill in these blank spaces.”

Related topics
,

Related conditions

Leave a Reply

Your email address will not be published. Required fields are marked *